🔬TODAY’S BREAKTHROUGH
A groundbreaking human trial shows that a single infusion of mesenchymal stem cell–derived extracellular vesicles (MSC-EVs) can significantly improve frailty scores and physical performance in older adults.
The Discovery:
In a double-blind, placebo-controlled trial, older adults with moderate frailty received one intravenous dose of MSC-EVs. Within three months, participants saw improved mobility, grip strength, and reduced inflammation, without serious adverse effects.
The Science:
Participants: 120 adults aged 65+ with moderate frailty.
Intervention: Single intravenous infusion of MSC-EVs vs. placebo.
Frailty Index: Significantly reduced in the treatment group at 3 months.
Physical Function: Chair-stand times improved; grip strength increased by ~15%.
Inflammatory Markers: IL-6 and TNF-alpha levels dropped notably post-treatment.
Safety: No treatment-related serious adverse events; mild transient reactions in <5% of participants.
Durability: Benefits persisted at 6-month follow-up in most participants.
Your Action:
While MSC-EV therapy is still experimental, these results reinforce the importance of targeting inflammation and cellular communication in combating frailty. Lifestyle measures such as resistance training, protein-rich diet, and anti-inflammatory nutrition remain proven strategies.
Bottom Line:
MSC-EVs could emerge as a safe, powerful therapy to restore physical resilience in aging adults.
Source:
Mesenchymal Stem Cell–Derived Extracellular Vesicles for the Treatment of Frailty: A Randomized Controlled Trial. Published: February 28, 2025.
How was today’s newsletter?
A Quick Favor:
We kindly ask you to check out the sponsor(s) that made this newsletter possible. Your support helps us continue sharing valuable insights and empowering your wellness journey.
Fact-based news without bias awaits. Make 1440 your choice today.
Overwhelmed by biased news? Cut through the clutter and get straight facts with your daily 1440 digest. From politics to sports, join millions who start their day informed.
LEARN MORE ABOUT OUR WORK
— Capilli Eternal
Disclaimer:
This newsletter is for informational purposes only and does not substitute professional medical advice. Always consult with a healthcare provider before making any changes to your health regimen.